Comparison
Abdominal Tuberculosis C0740652 vs 3 Methylglutaconic Aciduria Type 3 C0574084
Clinical comparison between Abdominal Tuberculosis and 3 Methylglutaconic Aciduria Type 3 for differential diagnosis and treatment planning.
Abdominal Tuberculosis C0740652
A form of tuberculosis affecting organs in the abdomen, including intestines and lymph nodes. It can cause pain, weight loss, and bowel problems. Treatment requires long-term antibiotic therapy under medical supervision.
3 Methylglutaconic Aciduria Type 3 C0574084
A genetic metabolic disorder that primarily affects the nervous system, often causing vision problems, movement difficulties, and cognitive challenges. Treatment involves supportive therapies and regular monitoring.
6 comparison axes
Onset
Abdominal Tuberculosis C0740652
Variable
3 Methylglutaconic Aciduria Type 3 C0574084
1-10
Onset patterns differ
Severity
Abdominal Tuberculosis C0740652
severe
3 Methylglutaconic Aciduria Type 3 C0574084
moderate
Different severity levels
Chronic
Abdominal Tuberculosis C0740652
Chronic
3 Methylglutaconic Aciduria Type 3 C0574084
Chronic
Differing course
Communicable
Abdominal Tuberculosis C0740652
Yes
3 Methylglutaconic Aciduria Type 3 C0574084
No
Different transmission
Body System
Abdominal Tuberculosis C0740652
infectious
3 Methylglutaconic Aciduria Type 3 C0574084
metabolic
Same/different system
Category
Abdominal Tuberculosis C0740652
infectious
3 Methylglutaconic Aciduria Type 3 C0574084
metabolic
Different category
Bottom line
abdominal-tuberculosis-C0740652 and 3-methylglutaconic-aciduria-type-3-C0574084 differ in severity, communicability, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abdominal Tuberculosis C0740652 | 3 Methylglutaconic Aciduria Type 3 C0574084 | Discriminating power |
|---|---|---|---|
| Abdominal pain and bowel change | May include abdominal pain, weight loss, and bowel problems from intestinal or nodal disease. | Abdominal disease is not a described core feature. | High |
| Neurologic and visual problems | Not the typical primary presentation of abdominal tuberculosis. | Often involves vision problems, movement difficulty, and cognitive challenges. | High |
| Exposure and communicability | Infectious and potentially communicable; exposure history may be relevant. | Genetic and not communicable. | Moderate |
When to favor each condition
Choose Abdominal Tuberculosis C0740652 when
Chronic abdominal symptoms with possible tuberculosis exposure
Pain, weight loss, or bowel problems plus infectious risk favor evaluation for abdominal tuberculosis.
Moderate
Need to assess a communicable infection
Tuberculosis can be transmitted, unlike the genetic condition.
High
Imaging or tissue suggests abdominal granulomatous infection
Intestine or lymph-node involvement supports this diagnosis over a metabolic disorder.
Moderate
Choose 3 Methylglutaconic Aciduria Type 3 C0574084 when
Childhood-onset neurologic and visual findings
Source data place onset around ages 1–10 with nervous-system effects.
Moderate
Family history suggesting a genetic metabolic disorder
Noncommunicable inheritance distinguishes it from tuberculosis.
Moderate
Abnormal organic-acid pattern without infection
Metabolic testing, not infection testing, is the relevant pathway; exact cutoffs are not established here.
Low
How key tests differ
| Test | Abdominal Tuberculosis C0740652 | 3 Methylglutaconic Aciduria Type 3 C0574084 | Interpretation |
|---|---|---|---|
| Microbiology or tissue evaluation | May support Mycobacterium tuberculosis in abdominal tissue or fluid. | Not expected to identify tuberculosis. | A positive result supports infection but does not exclude unrelated disease. |
| Urine organic acids | No characteristic metabolic pattern is established from these data. | May show 3-methylglutaconic acid elevation; exact cutoffs are not supplied. | An abnormal result is not itself a complete diagnosis. |
| Neurologic and ophthalmologic assessment | Usually not the primary diagnostic focus. | May document vision, movement, or cognitive involvement. | Findings require correlation with genetics and metabolic results. |
Prognosis comparison
Abdominal Tuberculosis C0740652
- Outcome
- Potentially treatable infection, but course can be severe and chronic.
- Factors
- Organ involvement, treatment adherence, drug response, and complications.
3 Methylglutaconic Aciduria Type 3 C0574084
- Outcome
- Chronic neurologic condition with generally moderate listed severity; outcome varies.
- Factors
- Degree of vision, movement, and cognitive involvement and access to support.
Time frame: Both may require long-term care; exact timelines are not established.
Diagnosis certainty, comorbidities, and individualized treatment response.
Complications comparison
| Complication | Presentation |
|---|---|
| Bowel or nodal complications | Possible bowel obstruction, fistula, or lymph-node disease; frequency is not established here. Not a typical described complication. Abdominal complications need urgent clinical assessment. |
| Vision and movement impairment | Not characteristic of isolated abdominal disease. Vision and movement difficulties may occur and need supportive care. Severity varies; no mortality figure is established here. |
| Treatment-related burden | Long supervised antibiotic therapy may cause adverse effects. Supportive therapy and monitoring carry a different burden; no doses are specified. Medication decisions belong to the treating clinician. |
Patient education highlights
- HighDifferent causes
One is an infection that can spread; the other is a noncommunicable genetic metabolic condition.
- HighSeek care for warning symptoms
Worsening abdominal pain, bowel obstruction signs, vision loss, or neurologic decline need prompt review.
- MediumFollow the care plan
Tuberculosis needs supervised antibiotics; the metabolic disorder needs supportive care and monitoring.